Shares of Express Scripts are moving higher before the opening bell after activist investor Carl Icahn ended a short-lived fight to scuttle Cigna's takeover of the pharmacy benefit manager.
Icahn said late Monday that he'll end his campaign to convince Cigna shareholders to vote against the roughly $52-billion deal this month. He noted that two prominent shareholder advisory firms support it and that there is significant stockholder overlap between the companies.
Icahn argued in a lengthy letter to fellow shareholders last week that Cigna was "dramatically overpaying" for Express Scripts. He says he holds stakes in each company.
Institutional Shareholder Services, as well as Glass Lewis & Co., came out in support of the deal.
Express Script shares climbed nearly 2 percent to $85.50 before markets opened Tuesday.
Before you consider The Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Cigna Group wasn't on the list.
While The Cigna Group currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
